CTXR Citius Pharmaceuticals, Inc. - Common Stock
$0,56
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 14, 2026
Zakres 52 tyg.
$0–$2
5% of range
Ocena Analityków
BUY
8 analysts
Cena Docelowa
$4
+614% upside
P/E (TTM)
-0.4
ROE
—
Marża Zysku Netto
—
CTXR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.56
Kapitalizacja Rynkowa
—
P/E (TTM)
-0.4
EPS (TTM)
$-3.38
Przychody (TTM)
—
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $2
CTXR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-3.38
2021-09-30
→
2025-09-30
Wolny przepływ pieniężny
—
2020-09-30
→
2021-09-30
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CTXR
Mediana porównawcza
P/E (TTM)
-0.4
53.4
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CTXR
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CTXR
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CTXR
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CTXR
Mediana porównawcza
CTXR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 2 25,0%
- Kup 4 50,0%
- Trzymaj 2 25,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-08-16
Niski
$4.00
Wysoki
$4.00
Średni cel
$4.00
+614,2%
Średnia cel
$4.00
+614,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.50%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 września 2025 | $-0.72 | $-0.50 | -0.22% |
| 30 czerwca 2025 | $-0.80 | $-0.60 | -0.20% |
| 31 marca 2025 | $-1.27 | $-0.39 | -0.88% |
| 31 grudnia 2024 | $-1.30 | $-0.59 | -0.71% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CTXR | — | -0.4 | — | — | — | — |
| AYTU | $20M | -3.0 | 1.8% | -20.4% | -54.5% | 69.0% |
| TXMD | $19M | -32.6 | 71.6% | -18.8% | -2.1% | — |
| QCLS | — | -0.5 | — | — | — | — |
| CALC | — | -3.3 | -29.7% | — | — | — |
| RKTO | — | — | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | $75.0K | $50.0K | $45.0K | · | · | |
| R&D Expense | $9M | $12M | $15M | $18M | $12M | $9M | $9M | $7M | $3M | $3M | $2M | $574 | |
| SG&A Expense | $19M | $18M | $15M | $12M | $10M | $8M | $6M | $6M | $6M | $4M | $946.6K | $183.0K | |
| Operating Expenses | $39M | $42M | $37M | $33M | $24M | $18M | $16M | $14M | $10M | $7M | $3M | $653.8K | |
| Operating Income | $-39M | $-42M | $-37M | $-33M | $-24M | $-18M | $-16M | $-14M | $-10M | $-7M | $-3M | $-653.8K | |
| Interest Expense | · | · | · | · | $10.8K | $15.7K | $16.4K | $15.8K | $850.8K | $9.0K | $7.5K | $93.1K | |
| Interest Income | $110.1K | $758.0K | $1M | $251.4K | $261.8K | $68.1K | $52.7K | · | · | $806 | · | · | |
| Other Non-op | $-157.7K | $3M | $5M | $251.4K | $477.5K | $162.6K | $36.2K | $1M | $-398.6K | $-846.4K | $348.0K | · | |
| Pretax Income | $-39M | $-39M | $-32M | $-33M | $-23M | $-18M | $-16M | $13M | $10M | $-8M | $-3M | $-737.7K | |
| Income Tax | $1M | $576.0K | $576.0K | $576.0K | $1.2K | $741 | · | · | · | · | · | · | |
| Net Income | $-40M | $-39M | $-33M | $-34M | $-23M | $-18M | $-16M | $-13M | $-10M | $-8M | $-3M | $-737.7K | |
| EPS (Basic) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | · | · | · | · | · | · | · | |
| Shares (Basic) | 11,065,225 | 6,726,999 | 6,051,789 | 146,082,399 | 108,599,080 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 11,065,225 | 6,726,999 | 6,051,789 | 146,082,399 | 108,599,080 | · | · | · | · | · | · | · | |
| EBITDA | · | · | $-37M | $-33M | $-24M | $-18M | $-16M | $-14M | · | $-7M | $-3M | · |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $26M | $42M | $70M | $14M | $8M | $9M | $3M | $294.4K | $676.1K | $2M | |
| Inventory | $22M | $8M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $3M | $8M | $3M | $3M | $122.2K | $48.1K | $57.7K | $220.2K | $598.5K | $60.0K | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $19M | · | · | |
| Current Assets | $28M | $14M | $34M | $45M | $73M | $14M | $8M | $10M | $3M | $892.8K | $736.1K | $2M | |
| PP&E (Net) | · | · | $1.4K | $4.1K | $7.0K | $1.6K | $590 | $1.5K | $3.2K | $3.7K | · | · | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $8.5K | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $4.8K | · | · | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $2M | $2M | $2M | · | · | |
| Other Non-current Assets | $102M | $102M | $69M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $131M | $117M | $104M | $114M | $142M | $44M | $37M | $31M | $24M | $22M | $741.5K | $2M | |
| Accounts Payable | $14M | $5M | $3M | $1M | $1M | $2M | $3M | $2M | $602.4K | $909.2K | $559.1K | $106.2K | |
| Accrued Liabilities | $4M | $17.0K | $476.3K | $1M | $622.0K | $164.0K | $246.2K | $181.7K | $560.9K | $958.1K | $8.3K | $60.3K | |
| Short-term Debt | $1M | · | · | · | · | $173.0K | $173.0K | $173.0K | $173.0K | $673.0K | · | · | |
| Current Liabilities | $45M | $36M | $6M | $5M | $4M | $4M | $5M | $3M | $2M | $5M | $1M | $2M | |
| Capital Leases | $724.9K | $21.3K | $262.9K | $481.2K | $678.2K | $855.5K | · | · | · | · | · | · | |
| Deferred Tax | $8M | $7M | $6M | $6M | $5M | $5M | $5M | · | · | · | · | · | |
| Total Liabilities | $53M | $43M | $12M | $11M | $10M | $10M | $10M | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | $173.0K | $173.0K | $173.0K | · | · | · | · | |
| Common Stock | $18.1K | $7.2K | $6.4K | $146.2K | $146.0K | $55.6K | $28.9K | $16.2K | $8.3K | $4.9K | $34.1K | $30.0K | |
| Paid-in Capital | $306M | $271M | $253M | $232M | $228M | $104M | $80M | $68M | $50M | $34M | $8M | $5M | |
| Retained Earnings | $-239M | $-201M | $-162M | $-130M | $-96M | $-71M | $-53M | $-40M | $-28M | $-17M | $-9M | $-6M | |
| Stockholders' Equity | $68M | $70M | $91M | $103M | $132M | $34M | $27M | $31M | $22M | $17M | $-635.2K | $-741.9K | |
| Liabilities + Equity | $131M | $117M | $104M | $114M | $142M | $44M | $37M | $31M | $24M | $22M | $741.5K | $2M | |
| Shares Outstanding | 18,067,744 | 7,247,243 | 6,354,371 | 146,211,130 | 145,979,429 | 55,576,996 | 28,930,493 | 16,198,791 | 8,345,844 | 4,875,871 | 34,117,886 | 30,025,295 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $12M | $7M | $4M | $1M | $803.3K | $716.0K | $779.7K | $986.6K | $732.2K | $732.2K | $470.2K | |
| Deferred Tax | $1M | $576.0K | $576.0K | $576.0K | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-27M | $-28M | $-29M | $-28M | $-24M | $-17M | $-12M | $-11M | $-8M | $-6M | $-2M | $-183.2K | |
| CapEx | · | · | · | · | $6.9K | $1.8K | · | · | $2.1K | · | · | · | |
| Investing Cash Flow | $-6M | $-5M | · | · | $-40M | $-1.8K | · | · | $-2.1K | $255.7K | · | · | |
| Stock Issued | $32M | $14M | · | · | $500 | · | · | · | · | · | · | $50.0K | |
| Net Stock Activity | · | · | · | · | $82.6K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $33M | $10M | $14M | · | $120M | $23M | $11M | $17M | $11M | $5M | $2M | $2M | |
| Net Change in Cash | · | · | · | · | · | · | $-1M | $6M | $3M | $-381.8K | $-875.9K | $1M | |
| Free Cash Flow | · | · | · | · | $-24M | $-17M | · | · | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -924229.7% | -105346.7% | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | -1029242.9% | -94659.8% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | -1029242.9% | -94659.8% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -924229.7% | -105346.7% | · | |
| ROA | · | · | -29.9% | -26.2% | -24.8% | -43.6% | -51.8% | -45.2% | · | -73.1% | -252.5% | · | |
| ROE | · | · | -33.6% | -28.6% | -27.8% | -59.6% | -64.0% | -50.6% | · | -102.8% | 421.5% | · | |
| ROIC | · | · | -41.2% | -33.0% | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 5.9 | 9.8 | 18.3 | 3.4 | 1.7 | 3.2 | · | 0.2 | 0.5 | · | |
| Quick Ratio | · | · | 4.6 | 9.2 | 17.6 | 3.4 | 1.7 | 2.9 | · | 0.1 | 0.5 | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | -2171.0 | -1130.0 | -948.6 | -870.6 | · | -828.3 | -430.7 | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · |
Wycena (TTM) 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-40M | $-39M | $-33M | $-34M | $-23M | $-18M | $-16M | $-13M | $-10M | $-8M | $-3M | · | |
| Market Cap | · | · | $2.72B | $4.42B | $7.41B | $1.45B | $548M | $692M | · | $17.28B | $21.75B | · | |
| Enterprise Value | · | · | · | · | · | $1.43B | $541M | $683M | · | · | · | · | |
| P/E | -0.4 | -2.1 | -3.1 | -131.5 | -220.7 | · | · | · | · | · | · | · | |
| P/B | · | · | 29.9 | 43.0 | 56.0 | 42.9 | 22.5 | 24.9 | · | 1030.6 | -34240.7 | · | |
| P / Tangible Book | 0.4 | 1.5 | 33.3 | 47.3 | 60.3 | 59.4 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -93.5 | -155.9 | -305.5 | -85.3 | -44.1 | -61.2 | · | -2928.4 | -9118.0 | · | |
| P / FCF | · | · | · | · | -305.4 | -85.3 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | -80.8 | -34.7 | -49.6 | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -84.5 | · | · | · | · | · | · | |
| Earnings Yield | -272.6% | -47.7% | -32.6% | -0.76% | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · |
Rachunek zysków i strat 18
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $491.8K | $328.9K | $789.2K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $1M | $1M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $1M | $2M | $2M | $2M | $2M | $4M | $2M | $3M | $3M | $4M | $3M | $3M | $4M | $5M | $3M | $4M | |
| SG&A Expense | $6M | $26M | $6M | $4M | $4M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $3M | $3M | |
| Operating Expenses | $13M | $34M | $12M | $8M | $9M | $11M | $10M | $11M | $11M | $11M | $9M | $10M | $9M | $11M | $7M | $8M | |
| Operating Income | $-12M | $-32M | $-9M | $-8M | $-9M | $-11M | $-10M | $-11M | $-11M | $-11M | $-9M | $-10M | $-9M | $-11M | $-7M | $-8M | |
| Interest Expense | $198.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $116.7K | $53.6K | $45.1K | $53.4K | $20.6K | $13.4K | $22.6K | $117.3K | $204.8K | $182.2K | $253.6K | $324.8K | $336.8K | $303.3K | $214.5K | $134.8K | |
| Other Non-op | $-294.5K | $4M | $-110.4K | $-42.1K | $-151.6K | $13.4K | $22.6K | $117.3K | $204.8K | $3M | $253.6K | $324.8K | $336.8K | $303.3K | $4M | · | |
| Pretax Income | $-12M | $-28M | $-9M | $-8M | $-9M | $-11M | $-10M | $-11M | $-10M | $-8M | $-9M | $-10M | $-8M | $-10M | $-3M | $-7M | |
| Income Tax | $-107.3K | $-231.2K | $264.2K | $264.2K | $264.2K | $264.2K | $264.2K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | · | |
| Net Income | $-12M | $-28M | $-9M | $-9M | $-9M | $-12M | $-10M | $-11M | $-11M | $-9M | $-9M | $-10M | $-8M | $-11M | $-4M | $-8M | |
| EPS (Basic) | $-0.34 | $-0.95 | $-0.38 | $-0.01 | $-0.80 | $-1.27 | $-1.30 | $-1.61 | $-1.57 | $-1.34 | $-1.45 | $-5.42 | $-0.06 | $-0.07 | $-0.02 | · | |
| EPS (Diluted) | $-0.34 | $-0.95 | $-0.38 | $-0.01 | $-0.80 | $-1.27 | $-1.30 | $-1.61 | $-1.57 | $-1.34 | $-1.45 | $-5.42 | $-0.06 | $-0.07 | $-0.02 | · | |
| Shares (Basic) | 26,169,589 | 22,376,427 | 21,495,274 | -16,015,338 | 11,006,896 | 8,581,207 | 7,492,460 | -12,948,406 | 6,954,278 | 6,362,890 | 6,358,237 | -440,186,666 | 153,775,380 | 146,251,945 | 146,211,130 | -292,101,252 | |
| Shares (Diluted) | 26,169,589 | 22,376,427 | 21,495,274 | -16,015,338 | 11,006,896 | 8,581,207 | 7,492,460 | -12,948,406 | 6,954,278 | 6,362,890 | 6,358,237 | -440,186,666 | 153,775,380 | 146,251,945 | 146,211,130 | -292,101,252 | |
| EBITDA | $-12M | $-32M | $-9M | · | $-9M | $-11M | $-10M | · | $-11M | $-11M | $-9M | · | $-9M | $-11M | $-7M | · |
Bilans 23
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $5M | $8M | $4M | $6M | $26.4K | $1M | $3M | $18M | $13M | $20M | $26M | $33M | $29M | $37M | $42M | |
| Receivables | $686.2K | $1M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $23M | $23M | $23M | $22M | $17M | $15M | $14M | $8M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $1M | $1M | $3M | $3M | $3M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $3M | |
| Current Assets | $43M | $32M | $38M | $28M | $25M | $18M | $18M | $14M | $28M | $22M | $28M | $34M | $41M | $35M | $42M | $45M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $275 | $854 | $1.4K | $2.0K | $2.6K | $3.4K | $4.1K | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $98M | $100M | $102M | $102M | $102M | $102M | $102M | $102M | · | · | · | $69M | · | · | · | · | |
| Total Assets | $142M | $133M | $140M | $131M | $128M | $121M | $121M | $117M | $97M | $91M | $97M | $104M | $110M | $104M | $112M | $114M | |
| Accounts Payable | $8M | $9M | $11M | $14M | $10M | $9M | $7M | $5M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $26M | $24M | $5M | $4M | $9M | $9M | $6M | $17.0K | $550.5K | $151.2K | $276.9K | $476.3K | $892.9K | $2M | $690.4K | $1M | |
| Short-term Debt | · | · | $1M | $1M | $1M | $300M | $300M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $52M | $55M | $38M | $45M | $52M | $50M | $45M | $36M | $4M | $4M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Capital Leases | $590.8K | $636.7K | $681.6K | $724.9K | $767.0K | $786.7K | · | $21.3K | $84.4K | $145.1K | $204.6K | $262.9K | $320.0K | $374.8K | $428.6K | $481.2K | |
| Deferred Tax | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Total Liabilities | $66M | $63M | $47M | $53M | $60M | $58M | $52M | $43M | $11M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | |
| Total Debt | · | · | $1M | · | $1M | $300M | $300M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $27.5K | $22.4K | $22.4K | $18.1K | $14.5K | $8.8K | $7.7K | $7.2K | $180.7K | $159.1K | $159.0K | $6.4K | $158.9K | $146.4K | $146.2K | $146.2K | |
| Paid-in Capital | $344M | $330M | $327M | $306M | $296M | $283M | $277M | $271M | $276M | $259M | $256M | $253M | $250M | $235M | $234M | $232M | |
| Retained Earnings | $-277M | $-268M | $-247M | $-239M | $-231M | $-222M | $-211M | $-201M | $-191M | $-180M | $-171M | $-162M | $-152M | $-144M | $-133M | $-130M | |
| Stockholders' Equity | $67M | $62M | $80M | $68M | $65M | $61M | $65M | $70M | $86M | $79M | $85M | $91M | $98M | $91M | $100M | $103M | |
| Liabilities + Equity | $142M | $133M | $140M | $131M | $128M | $121M | $121M | $117M | $97M | $91M | $97M | $104M | $110M | $104M | $112M | $114M | |
| Shares Outstanding | 27,452,570 | 22,376,427 | 22,376,427 | 18,067,744 | 14,475,029 | 8,760,649 | 7,727,243 | 7,247,243 | 180,725,407 | 159,094,781 | 158,966,576 | 6,354,371 | 158,857,798 | 146,357,797 | 146,211,130 | 146,211,130 |
Przepływy pieniężne 7
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $1M | $1M | $1M | $976.7K | |
| Deferred Tax | $-107.3K | $-231.2K | $264.2K | $264.2K | $264.2K | $264.2K | $264.2K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | · | |
| Operating Cash Flow | $-9M | $-1M | $-13M | $-12M | $-5M | $-5M | $-5M | $-6M | $-8M | $-8M | $-6M | $-7M | $-10M | $-8M | $-5M | $-6M | |
| Investing Cash Flow | $-2M | $-600.0K | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $4M | $-62.8K | $21M | $16M | $10M | $3M | $3M | $84.7K | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $21M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $23M | $-1M | $21M | $16M | $11M | $3M | $3M | $-4M | · | · | · | $-687 | $14M | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 80.3% | 80.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -785.4% | -1931.0% | -228.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -797.9% | -1686.0% | -238.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -805.1% | -1699.8% | -231.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -785.4% | -1931.0% | -228.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -8.8% | -22.1% | -7.2% | · | -8.2% | -10.8% | -9.4% | · | -10.2% | -8.8% | -8.8% | · | -7.3% | -9.1% | -2.9% | · | |
| ROE | -18.1% | -46.0% | -12.9% | · | -12.2% | -16.4% | -13.7% | · | -11.5% | -10.0% | -10.0% | · | -8.2% | -10.1% | -3.2% | · | |
| ROIC | -17.5% | -51.9% | -11.5% | · | -13.7% | -3.2% | -2.8% | · | -12.6% | -14.1% | -11.2% | · | -9.0% | -11.9% | -7.5% | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.6 | 1.0 | · | 0.5 | 0.4 | 0.4 | · | 6.7 | 5.2 | 5.1 | · | 7.1 | 5.6 | 9.3 | · | |
| Quick Ratio | 0.3 | 0.1 | 0.3 | · | 0.1 | 0.0 | 0.0 | · | 4.3 | 3.0 | 3.6 | · | 5.7 | 4.7 | 8.1 | · | |
| Debt / Equity | · | · | 0.0 | · | 0.0 | 4.9 | 4.6 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -59.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.4 | 3.1 | 1.9 | · | · | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | |
| Net Income TTM | $-59M | $-58M | $-40M | · | $-42M | $-41M | $-39M | · | $-37M | $-37M | $-32M | · | $-31M | $-31M | $-29M | · | |
| Market Cap | $17M | $20M | $17M | · | $23M | $13M | $31M | · | $2.64B | $3.57B | $3.01B | · | $4.77B | $4.28B | $2.89B | · | |
| Enterprise Value | · | · | $11M | · | $18M | $313M | $330M | · | · | · | · | · | · | · | · | · | |
| P/E | -0.2 | -0.3 | -0.2 | · | -0.3 | -0.3 | -0.7 | · | -3.3 | -7.7 | -11.8 | · | -142.9 | -146.2 | -103.9 | · | |
| P/B | 0.2 | 0.3 | 0.2 | · | 0.4 | 0.2 | 0.5 | · | 30.8 | 45.0 | 35.5 | · | 48.8 | 46.9 | 28.8 | · | |
| P / Tangible Book | 0.3 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.6 | · | 34.6 | 51.0 | 39.9 | · | 53.9 | 52.3 | 31.7 | · | |
| P / Cash Flow | · | · | -1.3 | · | · | · | -6.5 | · | · | · | -490.3 | · | · | · | -598.6 | · | |
| EV / EBITDA | · | · | -1.2 | · | -2.0 | -27.8 | -32.9 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -408.3% | -377.8% | -482.6% | · | -310.7% | -367.8% | -141.5% | · | -30.3% | -13.0% | -8.5% | · | -0.70% | -0.68% | -0.96% | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Zysk netto | $-40M | $-39M | $-33M | $-34M | $-23M |
| Rozwodniony EPS | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 |
Bilans
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | — | — | 5.9 | 9.8 | 18.3 |
| Wskaźnik Szybkości | — | — | 4.6 | 9.2 | 17.6 |
Przepływy pieniężne
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | — | — | — | $-24M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 45 emitentów · $848K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 15 (+8 vs poprzedni kw.) | 7 (-2 vs poprzedni kw.) | 7 (-2 vs poprzedni kw.) | 9 (+4 vs poprzedni kw.) | +533K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $119 405 | 197 364 | 14,08% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $107 290 | 177 469 | 12,66% | Akcje |
| VANGUARD GROUP INC | $93 019 | 119 715 | 10,97% | Akcje |
| Miller Financial Services LLC | $78 585 | 130 000 | 9,27% | Akcje |
| CITADEL ADVISORS LLC | $75 508 | 124 910 | 8,91% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $47 042 | 77 755 | 5,55% | Akcje |
| JANE STREET GROUP, LLC | $46 053 | 76 183 | 5,43% | Akcje |
| BlackRock, Inc. | $42 224 | 69 850 | 4,98% | Akcje |
| NORTHERN TRUST CORP | $37 928 | 62 742 | 4,47% | Akcje |
| XTX Topco Ltd | $35 786 | 59 199 | 4,22% | Akcje |
| Asset Advisory Group, Inc. | $35 672 | 59 011 | 4,21% | Akcje |
| BostonPremier Wealth LLC | $16 926 | 28 000 | 2,00% | Akcje |
| LPL Financial LLC | $15 381 | 25 445 | 1,81% | Akcje |
| STATE STREET CORP | $14 067 | 23 271 | 1,66% | Akcje |
| Arkadios Wealth Advisors | $12 090 | 20 000 | 1,43% | Akcje |
| UBS Group AG | $11 868 | 19 616 | 1,40% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $10 575 | 17 494 | 1,25% | Akcje |
| Sanctuary Advisors, LLC | $7 139 | 11 810 | 0,84% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 130 | 11 795 | 0,84% | Akcje |
| R Squared Ltd | $6 670 | 11 033 | 0,79% | Akcje |
| TWO SIGMA SECURITIES, LLC | $6 049 | 10 006 | 0,71% | Akcje |
| SBI Securities Co., Ltd. | $5 754 | 9 519 | 0,68% | Akcje |
| CHELSEA COUNSEL CO | $2 797 | 4 626 | 0,33% | Akcje |
| Quent Capital, LLC | $2 558 | 4 232 | 0,30% | Akcje |
| IFP Advisors, Inc | $2 529 | 4 183 | 0,30% | Akcje |
| Tower Research Capital LLC (TRC) | $1 647 | 2 724 | 0,19% | Akcje |
| OSAIC HOLDINGS, INC. | $1 543 | 2 575 | 0,18% | Akcje |
| GROUP ONE TRADING LLC | $938 | 1 551 | 0,11% | Akcje |
| SIMPLEX TRADING, LLC | $759 | 1 256 | 0,09% | Akcje |
| BARCLAYS PLC | $663 | 1 096 | 0,08% | Akcje |
| Integrated Wealth Concepts LLC | $605 | 1 000 | 0,07% | Akcje |
| WELLS FARGO & COMPANY/MN | $605 | 1 000 | 0,07% | Akcje |
| Luminist Capital LLC | $263 | 435 | 0,03% | Akcje |
| ASSETMARK, INC | $225 | 372 | 0,03% | Akcje |
| Princeton Global Asset Management LLC | $97 | 160 | 0,01% | Akcje |
| Smallwood Wealth Investment Management, LLC | $72 | 120 | 0,01% | Akcje |
| JPMORGAN CHASE & CO | $69 | 120 | 0,01% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $65 | 107 | 0,01% | Akcje |
| Arax Advisory Partners | $51 | 84 | 0,01% | Akcje |
| Federation des caisses Desjardins du Quebec | $48 | 80 | 0,01% | Akcje |
| MORGAN STANLEY | $27 | 44 | 0,00% | Akcje |
| Fairscale Capital, LLC | $25 | 42 | 0,00% | Akcje |
| WR Wealth Planners, LLC | $16 | 4 | 0,00% | Akcje |
| Virtu Financial LLC | $13 | 20 836 | 0,00% | Akcje |
| Bogart Wealth, LLC | $2 | 4 | 0,00% | Akcje |
Insiderzy spółki 11 insiderów · 4 dyrektorzy generalni · 9 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Leonard L Mazur | Chief Executive Officer | 8 sierpnia 2025 A | 10 255 343 | 0 | 0 | $0 |
| Jaime Bartushak | Chief Financial Officer | 7 listopada 2024 A | — | 0 | 0 | $0 |
| Myron Z Holubiak | Vice Chairman | 8 sierpnia 2025 A | 1 992 243 | 0 | 0 | $0 |
| Myron Czuczman | Chief Medical Officer | 7 listopada 2024 A | — | 0 | 0 | $0 |
| Robert Joseph Smith | Dyrektor | 7 listopada 2024 A | — | 0 | 0 | $0 |
| Eugene Myron Holuka | Dyrektor | 7 listopada 2024 A | 2 367 | 0 | 0 | $0 |
| Carol Webb | Dyrektor | 7 listopada 2024 A | 11 835 | 0 | 0 | $0 |
| Suren G Dutia | Dyrektor | 7 listopada 2024 A | — | 0 | 0 | $0 |
| Dennis M Mcgrath | Dyrektor | 7 listopada 2024 A | — | 0 | 0 | $0 |
| William Kane | Dyrektor | 4 października 2022 A | — | 0 | 0 | $0 |
| Howard Safir | Dyrektor | 4 października 2022 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Leonard L. Mazur ×3 zgłoszenia | 27 listopada 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Myron Z. Holubiak ×2 zgłoszenia | 18 lutego 2022 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 197 364 SH | 8 sierpnia 2026 | Dziennie |